“A national clinical pharmacy agreement and the ability to require reimbursement from paying third parties will result in greater pharmacist participation and strong evidence-based programs,” Rachel DeBarmore, BSPharm, Rite Aid Pharmacy District Manager in Beaverton, OR, told Today. After nearly 4 years of collaboration between national pharmacy associations and other stakeholders, Oregon has become the youngest state to implement the status of pharmacist supplier. The CDTM is an extension of the traditional practice of pharmacists, which allows for the management of drug-related problems (DPD) managed by pharmacists, with an emphasis on a collaborative and interdisciplinary approach to pharmacy practice in the health field. The conditions of a CPA are defined by the pharmacist and the cooperating physician, although models exist online. CPAs may be specific to a patient population of interest to both parties, a specific clinical situation or disease, and/or a factual protocol for managing the drug treatment of patients under CPA. CPAs have been the subject of intensive debate in pharmacy and medicine. The guidelines and legal requirements for the constitution of the CPA are defined on the basis of the state.  The federal government approved the CPAs in 1995.  Washington was the first state to pass laws allowing formal formation of CPAs. In 1979, Washington changed the practice of pharmaceutical requirements that provide for the formation of “collaborative drug therapy agreements.” [Citation required] Since February 2016, 48 states and Washington D.C have passed laws that allow the availability of CPAs.  The only two states that do not allow cpAs to be made available are Alabama and Delaware.  Alabama pharmacists hoped that a CPA law, House Bill 494, would be passed in 2015.  The bill was introduced by Alabama House Of Representatives Representative Ron Johnson, but died in committee.
 For pharmacists, I think you have reached one of the few crossroads that will determine the future of your profession. You will either be your place as a health care provider, or your numbers will decrease, as most donation activities will be replaced by robotics and pharmacy technicians. I am a doctor, and I say that our profession and the patients we serve need you “as a team” as pharmacists. But are you really going to join us?  CPAs are a lobbying priority for professional pharmaceutical organizations. In January 2012, the American Pharmacists Association (APhA) brought together a consortium of pharmacy, medical and care professionals from 12 countries to discuss the integration of CPAs into daily clinical practice.  The consortium published a white paper entitled “Consortium Recommendations for Advancing Pharmacists” Patients Care Services and Collaborative Practice Agreements and summarized their recommendations.  Arkansan CPAs apply to individual pharmacists, practitioners admitted as “authorized practitioners to prescribe drugs” and patients. The specific disease stipulates that pharmacists administer, with indicated medications that the pharmacist can use are necessary. Pharmacists are required to document their interventions for discussion with the collaborative practitioner and must keep these records for at least 2 years after the date of registration.
 In preparation, OSPA and OSHP stated that they already had pharmacists from hospital and outpatient sectors working on collaborative therapeutic protocols.